46 jobs for “Biotech Research Scientist”
Alloy Therapeutics UK Ltd Cambridge £45,000 – £50,000 pa
Design and build large-scale synthetic gene loci and transgenic platforms for antibody discovery, using CRISPR/Cas9, RMCE and site-specific integrases. Hands-on molecular biology including PCR, NGS, plasmid construction and flow-cytometric immunophenotyping, within a small multidisciplinary team working from dry-lab design to wet-lab validation.
CureAge Therapeutics London
Lead the computationally guided design of a lipid nanoparticle delivery platform, applying chemical and biophysical principles to optimise LNP composition and formulation. Use AI-enabled chemistry, cheminformatics, predictive models and molecular modelling to prioritise formulation components, working closely with the experimental team and founding team in a small start-up.
GSK USA - Pennsylvania - Upper Providence £174,750 – £291,250 pa
Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, accountable for at least one asset or disease area and its Global Epidemiology Plan. Designs and oversees complex observational studies using claims, EHR and registry data, advises clinical, safety and regulatory matrix teams, and manages external partnerships and scientific dissemination. Also mentors junior epidemiologists and represents the company with regulators and at international conferences.
GSK Boston, United States £174,750 – £320,375 pa
Leads respiratory epidemiology and real-world evidence programs that inform vaccine development, designing and overseeing complex studies on disease burden, treatment patterns and safety. Partners across clinical development, safety, regulatory and health outcomes, manages external collaborations, and mentors junior scientists. Hybrid role requiring on-site presence at least two days per week.
Isomorphic Labs Cambridge, United States
Lead DMPK strategy across drug discovery projects, designing screening cascades and mechanistic experiments while integrating DMPK, PD and toxicology data for dose and safety predictions. Work closely with AI/ML platform teams to optimise computational ADME models and author regulatory sections, in a hybrid Cambridge, MA role.
Isomorphic Labs London
Lead formulation strategy for small molecules across drug discovery and preclinical development, designing technologies such as solid dispersions and co-crystals to improve solubility, stability and manufacturability. Work within an interdisciplinary team alongside AI/ML drug design platform groups, managing external CRO resources and authoring regulatory submissions.
Basecamp Research London
Owns the peptide and protein platform as a commercial product, spanning market and competitive intelligence, target product profiles, roadmap and packaging decisions, and go-to-market positioning. Sits between model, data and science teams and business development, and is accountable for partner engagement and revenue generation. Requires deep peptide therapeutics and licensing deal expertise.
Basecamp Research London
Owns the end-to-end sample-to-sequence pipeline for the Trillion Gene Atlas, spanning DNA extraction, library prep and sequencing dispatch across Phase 1 and Phase 2. Bridges R&D and production by scaling validated protocols, applying Lean/Six Sigma to improve throughput, and leading a small lab team while monitoring data return with bioinformatics partners.
Novartis London
Leads end-to-end translational strategy for neurodegenerative and neuromuscular programs, bridging preclinical research to Phase 1–2 clinical development. Accountable for biomarker strategy, clinical endpoint selection and early-phase trial design, and serves as the Translational Medicine representative within global cross-functional project and clinical trial teams.
Ipsen London
Leads one or more Early Development Asset Teams, owning integrated strategy from candidate nomination through first-in-human trials across preclinical, translational, clinical, regulatory and CMC workstreams. Serves as scientific champion for oncology assets, presenting data and investment recommendations to governance bodies and contributing to in-licensing due diligence.
Vertex Pharmaceuticals London
Leads the development and execution of international regulatory strategy across European and Rest of World markets, from first-in-human through post-marketing. Represents Global Regulatory Affairs on core development teams, manages project plans and resources, and advises senior management. Also a people manager within the International GRA leadership team, driving process improvement and regulatory policy engagement.
Relation Therapeutics London
Senior project manager role coordinating a multi-year osteoporosis drug discovery programme across target ID, hit-to-lead, lead optimisation and candidate selection. Involves orchestrating matrixed wet lab, ML, data science and engineering teams plus CROs, managing plans, budgets, risks and governance, and translating scientific objectives into integrated timelines and milestones.
Ipsen London
Leads global operational delivery of early development oncology programs, managing Clinical Project Managers, Monitoring Leads and CTAs. Owns the clinical development plan, CRO and site selection strategy, budgets and timelines, and serves on Asset Teams. Requires deep first-in-human and Phase I oncology trial expertise.
Pfizer New York, United States US$176,600 – US$294,300 pa
Leads global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and patient-reported outcomes. Partners with cross-functional teams and country affiliates to support reimbursement and market access, managing vendors and budgets. Requires deep HTA and health economics expertise within a matrix organization.
Pfizer Europe - Any Pfizer Site US$176,600 – US$294,300 pa
Leads global health economics and outcomes research for a rare disease asset, developing evidence generation strategy and HEOR studies such as network meta-analyses, economic models and patient-reported outcomes. Oversees launch deliverables including value dossiers and systematic literature reviews, working with cross-functional and country teams to support reimbursement and patient access.
CSL Maidenhead
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
CSL Opfikon, Switzerland
Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.
